Literature DB >> 15294374

Use of CA125 fluctuation during the menstrual cycle as a tool in the clinical diagnosis of endometriosis; a preliminary report.

Hasan Kafali1, Hülya Artuc, Nurettin Demir.   

Abstract

OBJECTIVE: To elucidate whether endometriosis can be diagnosed clinically by assessing the differences between serum CA125 levels during menstruation and during the rest of the menstrual cycle.
METHODS: The study was performed in 28 patients who underwent laparoscopy to check for pelvic causes of infertility. Patients with endometriosis were selected as the study group, and patients with normal laparoscopic findings functioned as the control group. Blood specimens were taken for CA125 determination during menstruation and during the rest of the menstrual cycle. Mean serum CA125 concentrations were compared by the two-sample t-test for between-group comparisons and the paired t-test for within-group comparisons. The receiver operating characteristic curve was applied to assess the usefulness of CA125 level changes during the menstrual cycle in the clinical diagnosis of endometriosis.
RESULTS: The mean CA125 concentrations of healthy women during menstruation and during the rest of the menstrual cycle were 12.2 and 10 U ml(-1), respectively. In this group, the mean CA125 concentration was an average of 22% higher during menstruation than during the rest of the menstrual cycle (P < 0.001). The patients with endometriosis showed a similar pattern to that of normal women, but the levels differed by 198.3% in these patients (P < 0.001). Mean CA125 concentrations of these patients during menstruation and in the rest of the cycle were 35.8 and 12 U ml(-1), respectively. The mean CA125 concentration during menstruation was significantly higher in patients with endometriosis than in normal women (P < 0.001), but CA125 concentrations at other points in the menstrual cycle were found to be similar in both groups (P > 0.05). ROC curve analyses set a cutoff of 83% (percentage increment of CA125 level during menstruation compared with that on days without menstrual bleeding), which gives a sensitivity of 93% and specificity of 92%, with a corresponding likelihood ratio of 11.3.
CONCLUSIONS: It may be possible to diagnose endometriosis clinically by assessment of the differences in CA125 level during menstruation as against the remainder of the menstrual cycle.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15294374     DOI: 10.1016/j.ejogrb.2004.02.039

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  9 in total

Review 1.  Peripheral biomarkers of endometriosis: a systematic review.

Authors:  K E May; S A Conduit-Hulbert; J Villar; S Kirtley; S H Kennedy; C M Becker
Journal:  Hum Reprod Update       Date:  2010-05-12       Impact factor: 15.610

2.  Association of the neutrophil-to-lymphocyte ratio and CA 125 with the endometriosis score.

Authors:  Seul Ki Kim; Jung Yeon Park; Byung Chul Jee; Chang Suk Suh; Seok Hyun Kim
Journal:  Clin Exp Reprod Med       Date:  2014-12-31

3.  The detection, treatment, and biology of epithelial ovarian cancer.

Authors:  Jennifer Aa Gubbels; Nick Claussen; Arvinder K Kapur; Joseph P Connor; Manish S Patankar
Journal:  J Ovarian Res       Date:  2010-03-29       Impact factor: 4.234

Review 4.  Blood biomarkers for the non-invasive diagnosis of endometriosis.

Authors:  Vicki Nisenblat; Patrick M M Bossuyt; Rabia Shaikh; Cindy Farquhar; Vanessa Jordan; Carola S Scheffers; Ben Willem J Mol; Neil Johnson; M Louise Hull
Journal:  Cochrane Database Syst Rev       Date:  2016-05-01

5.  Ovarian tumor marker HE4 is differently expressed during the phases of the menstrual cycle in healthy young women.

Authors:  Emanuela Anastasi; Teresa Granato; Giulia Giovanna Marchei; Valentina Viggiani; Barbara Colaprisca; Sara Comploj; Maria Gabriella Reale; Luigi Frati; Cecilia Midulla
Journal:  Tumour Biol       Date:  2010-05-20

6.  How to Use CA-125 More Effectively in the Diagnosis of Deep Endometriosis.

Authors:  Marco Aurelio Pinho Oliveira; Thiers Soares Raymundo; Leila Cristina Soares; Thiago Rodrigues Dantas Pereira; Alessandra Viviane Evangelista Demôro
Journal:  Biomed Res Int       Date:  2017-06-04       Impact factor: 3.411

7.  Discovery of non-invasive biomarkers for the diagnosis of endometriosis.

Authors:  Stella Irungu; Dimitrios Mavrelos; Jenny Worthington; Oleg Blyuss; Ertan Saridogan; John F Timms
Journal:  Clin Proteomics       Date:  2019-04-06       Impact factor: 3.988

8.  Combination of noninvasive methods in diagnosis of infertile women with minimal or mild endometriosis, a retrospective study in China.

Authors:  Huaying Yu; Baijia Li; TinChiu Li; Songying Zhang; Xiaona Lin
Journal:  Medicine (Baltimore)       Date:  2019-08       Impact factor: 1.817

Review 9.  Novel diagnostic options for endometriosis - Based on the glycome and microbiome.

Authors:  Zsuzsanna Kovács; Louise Glover; Fiona Reidy; John MacSharry; Radka Saldova
Journal:  J Adv Res       Date:  2021-02-05       Impact factor: 10.479

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.